IRVINE, Calif. — January 16, 2023 — Immunis Inc. was featured by DelveInsight Business Research LLP as one of six companies with recent developments in researching a treatment for knee osteoarthritis. DelveInsight is a leading Business Consultant and Market Research Firm that examines the innovative landscape of the healthcare industry to inform decision-makers on critical issues and opportunities. For more information about the article, read here.